Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director William W. Burke sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $28.86, for a total value of $57,720.00. Following the sale, the director now owns 6,306 shares of the company’s stock, valued at approximately $181,991.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Tactile Systems Technology, Inc. (TCMD) traded down $0.82 during trading on Wednesday, reaching $27.19. The company had a trading volume of 176,200 shares, compared to its average volume of 204,071. Tactile Systems Technology, Inc. has a 1-year low of $14.37 and a 1-year high of $37.88. The company has a market capitalization of $495.83, a P/E ratio of 186.73, a P/E/G ratio of 4.59 and a beta of -0.69.
Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings results on Tuesday, November 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.02. Tactile Systems Technology had a return on equity of 4.75% and a net margin of 5.84%. The business had revenue of $28.28 million during the quarter, compared to the consensus estimate of $27.66 million. During the same quarter in the prior year, the company posted $0.01 earnings per share. Tactile Systems Technology’s revenue was up 25.0% compared to the same quarter last year. sell-side analysts expect that Tactile Systems Technology, Inc. will post 0.31 EPS for the current fiscal year.
Several equities research analysts have recently commented on the company. Canaccord Genuity restated a “buy” rating and set a $37.00 price objective (up previously from $28.00) on shares of Tactile Systems Technology in a report on Tuesday, August 8th. BTIG Research upgraded Tactile Systems Technology from a “neutral” rating to a “buy” rating in a report on Thursday, November 9th. They noted that the move was a valuation call. Northland Securities restated a “hold” rating and set a $31.50 price objective on shares of Tactile Systems Technology in a report on Monday, October 16th. Zacks Investment Research downgraded Tactile Systems Technology from a “buy” rating to a “hold” rating in a report on Wednesday, October 11th. Finally, Guggenheim assumed coverage on Tactile Systems Technology in a report on Thursday, October 12th. They set a “buy” rating and a $47.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $34.25.
About Tactile Systems Technology
Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.
Receive News & Ratings for Tactile Systems Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.